Locations
hong kong · Boston, MA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
201-1000 employees
Stage
Series C+
founded in
2014
Insilico Medicine is a leading generative AI-driven biotech company focused on transforming drug discovery and development. Utilizing its proprietary Pharma.AI platform, the company accelerates the drug development process by integrating biology, chemistry, and clinical development. Insilico's innovative approach includes the application of generative adversarial networks (GANs) and reinforcement learning to discover novel drug candidates efficiently. The company is recognized for its end-to-end pipeline that encompasses all stages of drug discovery, from target identification to clinical trial analysis. With a strong emphasis on AI-driven solutions, Insilico Medicine is positioned as a pioneer in the biotech industry, addressing various diseases including cancer, neurodegenerative disorders, and age-related conditions.
Something looks off?